9.59
Schlusskurs vom Vortag:
$9.44
Offen:
$9.49
24-Stunden-Volumen:
1.05M
Relative Volume:
0.76
Marktkapitalisierung:
$1.29B
Einnahmen:
$3.26B
Nettoeinkommen (Verlust:
$-214.34M
KGV:
-5.8121
EPS:
-1.65
Netto-Cashflow:
$229.32M
1W Leistung:
+4.81%
1M Leistung:
+0.42%
6M Leistung:
-10.21%
1J Leistung:
-14.53%
Adapthealth Corp Stock (AHCO) Company Profile
Firmenname
Adapthealth Corp
Sektor
Branche
Telefon
610-424-4515
Adresse
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Vergleichen Sie AHCO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AHCO
Adapthealth Corp
|
9.59 | 1.27B | 3.26B | -214.34M | 229.32M | -1.65 |
![]()
ABT
Abbott Laboratories
|
126.35 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
105.84 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
SYK
Stryker Corp
|
400.69 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
91.97 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.49 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-01-08 | Herabstufung | Jefferies | Buy → Hold |
2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
2023-05-10 | Herabstufung | Deutsche Bank | Buy → Hold |
2023-05-10 | Herabstufung | Stifel | Buy → Hold |
2023-05-09 | Herabstufung | BofA Securities | Buy → Neutral |
2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
2021-07-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2021-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2021-03-18 | Eingeleitet | Truist | Buy |
2021-01-26 | Eingeleitet | BofA Securities | Buy |
2020-12-10 | Eingeleitet | UBS | Buy |
2020-08-10 | Eingeleitet | Canaccord Genuity | Buy |
2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
2020-06-09 | Eingeleitet | RBC Capital Mkts | Outperform |
2020-01-31 | Eingeleitet | Stifel | Buy |
2020-01-07 | Eingeleitet | Jefferies | Buy |
2019-12-11 | Eingeleitet | SVB Leerink | Outperform |
2019-12-10 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Adapthealth Corp Aktie (AHCO) Neueste Nachrichten
What is AdaptHealth Corp. company’s growth strategyInvest confidently with real-time market updates - jammulinksnews.com
What institutional investors are buying AdaptHealth Corp. stockAchieve breakthrough gains with smart trades - jammulinksnews.com
What markets is FBIN expanding into Is AdaptHealth Corp. stock a good long term investment optionBoost your returns with professional guidance - jammulinksnews.com
Will AdaptHealth Corp. stock benefit from AI tech trendsFree Stock Market Analysis Courses - metal.it
What makes AdaptHealth Corp. stock price move sharplyFree Stock Market Forums - Metal.it
What drives AdaptHealth Corp. stock priceMassive profits - Autocar Professional
What analysts say about AdaptHealth Corp. stockFree Consultation - Autocar Professional
Where are the Opportunities in (AHCO) - news.stocktradersdaily.com
BlackRock, Inc. Reduces Stake in AdaptHealth Corp: Analyzing the Implications - GuruFocus
Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price - simplywall.st
AdaptHealth Corp. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com
AdaptHealth to Announce Q2 2025 Financial Results on August 5 - MSN
Is AdaptHealth Corp. a good long term investmentHigh-margin investment plays - jammulinksnews.com
Briefly: AdaptHealth to Discuss Financial Results; AARC Seeking Zenith Award Nominees - HME Business
Truist Financial Remains Bullish on AdaptHealth (AHCO) - MSN
4 'Strong Buy' Stocks Under $10 with Up to 55% Upside - Investing.com
AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call - Business Wire
(AHCO) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Is the Options Market Predicting a Spike in AdaptHealth Stock? - Nasdaq
AdaptHealth Sells Infusion Assets, Advances Debt Reduction Strategy - MSN
AdaptHealth’s SWOT analysis: stock resilience amid market challenges - Investing.com
AdaptHealth Corp.: Divesting for Survival and Shareholder Value - AInvest
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph
AdaptHealth stock maintains Buy rating at Truist after infusion asset sale - Investing.com Canada
AdaptHealth Latest Strategic Move: $65M Debt Slash from Healthcare Asset Sale Signals Major Restructuring - Stock Titan
AdaptHealth Corp.(NasdaqCM:AHCO) dropped from Russell Small Cap Comp Growth Index - MarketScreener
AdaptHealth Completes Infusion Asset Sale; 2025 Outlook Updated - MarketScreener
Truist reiterates buy rating on AdaptHealth stock citing market position - Investing.com
Is AdaptHealth Corp. overvalued or undervalued? - MarketsMojo
AdaptHealth Approves Key Proposals at Annual Meeting - TipRanks
AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business - Yahoo Finance
AdaptHealth Q1 Net Loss Widens as Revenue Drops - MarketScreener
Finanzdaten der Adapthealth Corp-Aktie (AHCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):